PSEN1 and Alzheimer disease: The studies performed by the group of Dr. Scarpa suggest that, at least in rodents and in neuronal cell cultures, SAM administration is able to attenuate the epigenetic modification of AD-related genes, particularly PSEN1, induced by B vitamin depletion [133,141], leading to the speculation that something similar could happen also in humans.